An Clinical Study Evaluating the Safety, Tolerability, and efficAcy of HG005 in StaRgardT Disease

NCT07063251 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Stargardt Disease Type 1 (STGD1)

Interventions

GENETIC: HG005

Sponsor

HuidaGene Therapeutics Co., Ltd.